Association study of DTNBP1 with schizophrenia in a US sample
- PMID: 19862852
- PMCID: PMC2771321
- DOI: 10.1097/ypg.0b013e32832a50bc
Association study of DTNBP1 with schizophrenia in a US sample
Abstract
Background: Straub et al. (2002b) located a susceptibility region for schizophrenia at the DTNBP1 locus. At least 40 studies (including one study in US populations) attempted to replicate this original finding, but the reported findings are highly diverse and at least five pathways by which dysbindin protein might be involved in schizophrenia have been proposed. This study aimed to test the association in two common US populations by using powerful analytic methods.
Methods: Six markers at DTNBP1 were genotyped by mass spectroscopy ('MassARRAY' technique) in a sample of 663 individuals, including 346 healthy individuals European-Americans (EAs) and 48 African-Americans (AAs), and 317 individuals with schizophrenia (235 EAs and 82 AAs). Thirty-eight ancestry-informative markers were genotyped in this sample to infer the ancestry proportions. Diplotype, haplotype, genotype, and allele frequency distributions were compared between the cases and controls, controlling for possible population stratification, admixture, and sex-specific effects, and taking interaction effects into account, using a logistic regression analysis (an extended structured association method).
Results: Conventional case-control comparisons showed that genotypes of the markers P1578 (rs1018381) and P1583 (rs909706) were nominally associated with schizophrenia in EAs and in AAs, respectively. These associations became less or nonsignificant after controlling for population stratification and admixture effects (using structured association or regression analysis), and became nonsignificant after correction for multiple testing. However, regression analysis showed that the common diplotypes (ACCCTT/GCCGCC or GCCGCC/GCCGCC) and the interaction effects of haplotypes GCCGCC/GCCGCC significantly affected risk for schizophrenia in EAs, effects that were modified by sex. Fine-mapping using d or J statistics located the specific markers (d: P1328; J: P1333) closest to the putative risk sites in EAs.
Conclusion: This study shows that DTNBP1 is a risk gene for schizophrenia in EAs. Variation at DTNBP1 may modify risk for schizophrenia in this population.
Similar articles
-
The efficacies of clozapine and haloperidol in refractory schizophrenia are related to DTNBP1 variation.Pharmacogenet Genomics. 2009 Jun;19(6):437-46. doi: 10.1097/FPC.0b013e32832b9cfc. Pharmacogenet Genomics. 2009. PMID: 19369910 Free PMC article. Clinical Trial.
-
Association of the DTNBP1 locus with schizophrenia in a U.S. population.Am J Hum Genet. 2004 Nov;75(5):891-8. doi: 10.1086/425279. Epub 2004 Sep 10. Am J Hum Genet. 2004. PMID: 15362017 Free PMC article.
-
A reappraisal of the association between Dysbindin (DTNBP1) and schizophrenia in a large combined case-control and family-based sample of German ancestry.Schizophr Res. 2010 May;118(1-3):98-105. doi: 10.1016/j.schres.2009.12.025. Epub 2010 Jan 18. Schizophr Res. 2010. PMID: 20083391 Free PMC article.
-
Is the dysbindin gene (DTNBP1) a susceptibility gene for schizophrenia?Schizophr Bull. 2005 Oct;31(4):800-5. doi: 10.1093/schbul/sbi061. Epub 2005 Sep 15. Schizophr Bull. 2005. PMID: 16166606 Review.
-
The genes for schizophrenia: finally a breakthrough?Curr Psychiatry Rep. 2004 Aug;6(4):303-12. doi: 10.1007/s11920-004-0081-1. Curr Psychiatry Rep. 2004. PMID: 15260947 Review.
Cited by
-
The efficacies of clozapine and haloperidol in refractory schizophrenia are related to DTNBP1 variation.Pharmacogenet Genomics. 2009 Jun;19(6):437-46. doi: 10.1097/FPC.0b013e32832b9cfc. Pharmacogenet Genomics. 2009. PMID: 19369910 Free PMC article. Clinical Trial.
-
Synaptic dysbindin-1 reductions in schizophrenia occur in an isoform-specific manner indicating their subsynaptic location.PLoS One. 2011 Mar 1;6(3):e16886. doi: 10.1371/journal.pone.0016886. PLoS One. 2011. PMID: 21390302 Free PMC article.
-
Genetic Testing for Antipsychotic Pharmacotherapy: Bench to Bedside.Behav Sci (Basel). 2021 Jun 30;11(7):97. doi: 10.3390/bs11070097. Behav Sci (Basel). 2021. PMID: 34209185 Free PMC article. Review.
-
Losing your inhibition: linking cortical GABAergic interneurons to schizophrenia.Neurobiol Dis. 2013 May;53:36-48. doi: 10.1016/j.nbd.2012.11.013. Epub 2012 Nov 29. Neurobiol Dis. 2013. PMID: 23201207 Free PMC article. Review.
-
The DTNBP1 (dysbindin-1) gene variant rs2619522 is associated with variation of hippocampal and prefrontal grey matter volumes in humans.Eur Arch Psychiatry Clin Neurosci. 2013 Feb;263(1):53-63. doi: 10.1007/s00406-012-0320-0. Epub 2012 May 13. Eur Arch Psychiatry Clin Neurosci. 2013. PMID: 22580710 Free PMC article.
References
-
- Aleman A, Kahn RS, Selten JP. Sex differences in the risk of schizophrenia: evidence from meta-analysis. Arch Gen Psychiatry. 2003;60:565–571. - PubMed
-
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders, third edition, revised. Washington, DC: American Psychiatric Press; 1987.
-
- Benson MA, Newey SE, Martin-Rendon E, Hawkes R, Blake DJ. Dysbindin, a novel coiled-coil-containing protein that interacts with the dystrobrevins in muscle and brain. J Biol Chem. 2001;276:24232–24241. - PubMed
-
- Blouin AG, Perez EL, Blouin JH. Computerized administration of the diagnostic interview schedule. Psychiatry Res. 1988;23:335–344. - PubMed
-
- Bray NJ, Buckland PR, Owen MJ, O’Donovan MC. Cis-acting variation in the expression of a high proportion of genes in human brain. Hum Genet. 2003;113:149–153. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 DA012690/DA/NIDA NIH HHS/United States
- R01-DA12849/DA/NIDA NIH HHS/United States
- R01 DA012849/DA/NIDA NIH HHS/United States
- M01-RR06192/RR/NCRR NIH HHS/United States
- K02-MH01387/MH/NIMH NIH HHS/United States
- R01-AA11330/AA/NIAAA NIH HHS/United States
- K08-AA13732/AA/NIAAA NIH HHS/United States
- K24-AA13736/AA/NIAAA NIH HHS/United States
- R01 AA011330/AA/NIAAA NIH HHS/United States
- P50 AA012870/AA/NIAAA NIH HHS/United States
- R01 AA016015/AA/NIAAA NIH HHS/United States
- P50-AA12870/AA/NIAAA NIH HHS/United States
- K24-DA15105/DA/NIDA NIH HHS/United States
- K24 DA015105/DA/NIDA NIH HHS/United States
- K02 MH001387/MH/NIMH NIH HHS/United States
- K24 AA013736/AA/NIAAA NIH HHS/United States
- M01 RR006192/RR/NCRR NIH HHS/United States
- R01-DA12690/DA/NIDA NIH HHS/United States
- K08 AA013732/AA/NIAAA NIH HHS/United States
- R01-AA0-16015/AA/NIAAA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical